Medical News

RSS

New research: NFKBIA gene loss induces glioblastoma development

New research shows that loss of a gene called NFKBIA promotes the growth of glioblastoma multiforme, the most common and deadly form of brain cancer, and suggests that therapies that stabilize this gene may improve survival for certain glioblastoma patients.

7 Jan 2011

TPRF provides clean water, sanitation, hygiene education to Haitians affected by cholera outbreak

The Prem Rawat Foundation is continuing its support of efforts to aid Haitians affected by the recent cholera outbreak by providing approximately 13,000 people with access to clean water, sanitation goods, and hygiene education.

7 Jan 2011

Isis Pharmaceuticals announces addition of two new drugs to development pipeline

Isis Pharmaceuticals, announced today that it has added two new drugs to its development pipeline, ISIS-FGFR4Rx and ISIS-STAT3Rx.

7 Jan 2011

Liver transplant recipients develop PTMS, face high risk of cardiovascular disease

Researchers from Israel have determined that more than half of liver transplant recipients develop post-transplantation metabolic syndrome, placing them at greater risk for cardiovascular disease.

7 Jan 2011

Elevated fat and cholesterol levels in diet may play a role in breast cancer development

Elevated fat and cholesterol levels found in a typical American-style diet play an important role in the growth and spread of breast cancer, say researchers at the Kimmel Cancer Center at Jefferson.

7 Jan 2011

Researchers discover specific genetic abnormalities in hESC, iPSC lines

A multinational team of researchers led by stem cell scientists at the University of California, San Diego School of Medicine and Scripps Research Institute has documented specific genetic abnormalities that occur in human embryonic and induced pluripotent stem cell lines.

7 Jan 2011

CeNeRx commences TriRima Phase II trial for treatment resistant depression

CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.

7 Jan 2011

Robo4 molecule may improve bone marrow transplants: Study

Researchers at the University of California, Santa Cruz, have identified a key molecule for establishing blood stem cells in their niche within the bone marrow. The findings, reported in the January issue of Cell Stem Cell, may lead to improvements in the safety and efficiency of bone marrow transplants.

7 Jan 2011

FDA introduces new Web resource that helps companies to save time, resources

The U.S. Food and Drug Administration today introduced a new Web resource called FDA Basics for Industry to help companies and others save time and resources in their interactions with the agency.

7 Jan 2011

Dade Medical College officially launches new School of Continuing Education on Jan 22

Dade Medical College will officially introduce its new School of Continuing Education on January 22. This new division will begin offering non-credit courses for students and working professionals.

6 Jan 2011

GT Life Sciences and BGI complete CHO-K1 genome sequencing

GT Life Sciences, a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, and BGI, the largest genomics organization in the world, announced that they have successfully completed for the first time the sequencing of the Chinese hamster ovary genome.

6 Jan 2011

Researchers develop simple blood test to track Alzheimer's disease

Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer's disease with a simple blood test.

6 Jan 2011

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Altheus Therapeutics, announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.

6 Jan 2011

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.

6 Jan 2011

Cornerstone Healthcare Plus announces acquisition of Hedgcoxe Health Plaza Medical Office Building

Cornerstone Real Estate Funds and its strategic alliance partner and sub-advisor, Servant Healthcare Investments, announced that Cornerstone Healthcare Plus REIT has acquired the Hedgcoxe Health Plaza Medical Office Building in Plano, TX, from Hedgcoxe MOB Partners, L.P. The contract price for the property is approximately $9.0 million.

6 Jan 2011

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

6 Jan 2011

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Colorectal cancer (CRC) is the third most common cancer in men and women in the USA, with a new diagnosis made every 3.5 minutes and an associated death every 9 minutes.

6 Jan 2011

Lab21 acquires Microgen Bioproducts

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine and clinical diagnostics, has announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health.

6 Jan 2011

Tomatoes contain nutrient which prevents vascular diseases

They are the most widely produced fruit in the world and now scientists in Japan have discovered that tomatoes contain a nutrient which could tackle the onset of vascular diseases. The research, published in the journal Molecular Nutrition & Food Research, reveals that an extracted compound, 9-oxo-octadecadienoic, has anti-dyslipidemic affects.

6 Jan 2011

Tobacco product regulations announced by FDA

This Wednesday the Food and Drug Administration (FDA) released guidelines regarding agency approval for certain types of new products to be obtained by tobacco-product makers. FDA announced that products such as cigarettes, roll-your-own tobacco and smokeless products that were introduced or changed after Feb. 15, 2007 must be reviewed by the agency to show that they are “substantially equivalent” to products commercially available on Feb. 15, 2007.

6 Jan 2011

Medical News

New research: NFKBIA gene loss induces glioblastoma development

TPRF provides clean water, sanitation, hygiene education to Haitians affected by cholera outbreak

Isis Pharmaceuticals announces addition of two new drugs to development pipeline

Liver transplant recipients develop PTMS, face high risk of cardiovascular disease

Elevated fat and cholesterol levels in diet may play a role in breast cancer development

Researchers discover specific genetic abnormalities in hESC, iPSC lines

CeNeRx commences TriRima Phase II trial for treatment resistant depression

Robo4 molecule may improve bone marrow transplants: Study

FDA introduces new Web resource that helps companies to save time, resources

Dade Medical College officially launches new School of Continuing Education on Jan 22

GT Life Sciences and BGI complete CHO-K1 genome sequencing

Researchers develop simple blood test to track Alzheimer's disease

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

Cornerstone Healthcare Plus announces acquisition of Hedgcoxe Health Plaza Medical Office Building

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Lab21 acquires Microgen Bioproducts

Tomatoes contain nutrient which prevents vascular diseases

Tobacco product regulations announced by FDA

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News